The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Sympathetic Ganglion Block
Launched by SEOUL NATIONAL UNIVERSITY · Nov 8, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different procedures to help relieve chronic pain in the upper limb. Specifically, it compares two types of sympathetic nerve blocks: one guided by ultrasound (called the stellate ganglion block) and the other guided by X-ray (called the thoracic sympathetic nerve block). The goal is to see which method is more effective for patients suffering from conditions like complex regional pain syndrome or postherpetic neuralgia.
To be eligible for this trial, participants need to be adults aged 19 to 85 who have been experiencing chronic pain in their arms for more than three months. Patients will be randomly assigned to one of the two treatment groups, and the procedure will involve measuring temperature changes in their hands before and after the block to assess its effectiveness. Participants will also be asked questions about their pain and any side effects at various times during the study. Importantly, patients who have certain medical conditions or previous surgeries related to these nerves may not be eligible to participate. This trial is currently not recruiting participants, but it aims to provide valuable insights into pain management options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients with 19 - 85 years
- • Patients with chronic upper extremity pain that lasts for more than 3 months
- • Neuropathic pain conditions such as postherpetic neuralgia, complex regional pain syndrome, post laminectomy syndrome of cervical spine
- • Patients judged to require sympathetic blockade by pain physician
- Exclusion Criteria:
- • Patient refusal
- • Presence of upper limb vascular disorders
- • History of previous thoracic sympathetic ganglion removal or neurolysis
- • Abnormal findings in blood coagulation tests
- • Systemic infection or local injection site infection
- • Anatomical deformities at the injection site
- • Allergic reactions to the injected medications
- • Higher baseline hand temperature on the procedure side than the tympanic temperature (36.5°C) on pre-procedure thermography
- • Other cases deemed inappropriate by the investigator
About Seoul National University
Seoul National University (SNU), a prestigious institution located in South Korea, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient outcomes. Renowned for its commitment to innovation and excellence, SNU collaborates with a diverse network of healthcare professionals and researchers to conduct rigorous studies across various fields of medicine. The university's robust infrastructure and emphasis on interdisciplinary collaboration enable the development of novel therapeutic strategies and the exploration of cutting-edge technologies, ultimately contributing to the global body of medical knowledge and enhancing healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Jee Youn Moon, MD, PhD
Principal Investigator
Seoul National University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported